Evotec Seals Deal With Pfizer In Tissue Fibrosis
This article was originally published in Scrip
Executive Summary
Following swiftly on from its immuno-oncology therapy deal with Sanofi, Evotec has agreed on a four-year research collaboration with Pfizer in tissue fibrosis.